Novel resveratrol analogues attenuate renal ischemic injury in rats

Adam Khader, Weng Lang Yang, Michael Kuncewitch, Jose M. Prince, Philippe Marambaud, Jeffrey Nicastro, Gene F. Coppa, Ping Wang

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Background Renal ischemia-reperfusion (I/R) is a severe clinical complication with no specific treatment. Resveratrol has been shown as a promising experimental agent in renal I/R due to its effect on cellular energy metabolism, oxidative stress, and inflammation. Recently, we identified two biologically active resveratrol analogues (RSVAs), RSVA405 and RSVA314. We hypothesized that both RSAVs would attenuate I/R-induced renal injury.

Methods Adult male rats were subjected to renal I/R through bilateral renal pedicle clamping for 60 min, followed by reperfusion. RSVA405 (3 mg/kg Body Weight), RSVA314 (3 mg/kg Body Weight), or vehicle (10% dimethyl sulfoxide and 33% Solutol in phosphate buffered saline) were administered by intraperitoneal injection 1 h before ischemia. Blood and renal tissues were collected 24 h after I/R for evaluation.

Results Administration of RSVA405 and RSVA314 significantly reduced the serum levels of renal dysfunction and injury markers, including creatinine, blood urea nitrogen, aspartate aminotransferase, and lactate dehydrogenase, compared with vehicle. The protective effect of RSVA405 and RSVA314 was also reflected on histologic evaluation. Both RSVAs reduced the number of apoptotic cells by more than 60% as determined by transferase dUTP nick end labeling assay, compared with vehicle. The renal adenosine triphosphate levels of the vehicle group was decreased to 52.4% of control, whereas those of the RSVA405 and RSVA314 groups were restored to 72.3% and 79.6% of control, respectively. Both RSVAs significantly reduced the protein expression of inducible nitric oxide synthase and nitrotyrosine and the messenger RNA levels of tumor necrosis factor-α, interleukin-6, and interleukin-1β.

Conclusions RSVA405 and RSVA314 attenuate I/R-induced renal injury through the modulation of energy metabolism, oxidative stress, and inflammation.

Original languageEnglish (US)
Pages (from-to)807-815
Number of pages9
JournalJournal of Surgical Research
Volume193
Issue number2
DOIs
StatePublished - Feb 1 2015

Keywords

  • Energy metabolism
  • Inflammation
  • Oxidative stress
  • Renal ischemia-reperfusion
  • Resveratrol analogues

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Novel resveratrol analogues attenuate renal ischemic injury in rats'. Together they form a unique fingerprint.

Cite this